Anthrax as a Bioweapon — MCQs
Post-exposure prophylaxis is indicated in?
What is the diagnosis of a child with a small abrasion over the face who develops fever with chills, induration, and fiery red swelling over the face extending to the ear?
An organism produces cutaneous disease (malignant pustule or eschar) at the site of inoculation in handlers of animal skins. Most likely organism is:
Management of non-immunized diphtheria contacts includes all except:
Bacillus anthracis is:
A patient with acute leukemia is admitted with febrile neutropenia. On day four of being treated with broad-spectrum antibiotics, his fever increases. Chest X-ray shows bilateral fluffy infiltrates. Which of the following should be the most appropriate next step in the management?
Pulmonary manifestation for inhalational anthrax is:
Which of the following is classified as a Category A bioterrorism agent?
Targeted critical agents used in a bioterrorist event are except?
Category A bioterrorism agent is:
Anthrax as a Bioweapon Indian Medical PG Practice Questions and MCQs
Question 1: Post-exposure prophylaxis is indicated in?
- A. Rabies
- B. Diphtheria
- C. HBV
- D. All of the options (Correct Answer)
Explanation: ***All of the options*** - Post-exposure prophylaxis (PEP) is a critical intervention for various infectious diseases, including **Rabies**, **Diphtheria**, and **HBV**, to prevent disease development after exposure. - The specific PEP regimen varies by disease but generally involves **vaccines**, **immunoglobulins**, or **antiviral medications**. **Rabies PEP:** - Rabies PEP is indicated after potential exposure to a rabid animal and involves a series of **rabies vaccine** doses and, for unvaccinated individuals, **rabies immune globulin (RIG)**. - Rabies is almost always fatal once symptoms appear, making timely PEP crucial. **Diphtheria PEP:** - Diphtheria PEP is recommended for close contacts of individuals with confirmed diphtheria and typically involves administering a **booster dose of diphtheria toxoid vaccine** and sometimes **antibiotics**. - This helps prevent the spread of *Corynebacterium diphtheriae* and disease development in exposed individuals. **HBV PEP:** - HBV PEP is critical after percutaneous or mucosal exposure to **HBV-infected blood** or body fluids. - It usually includes administering **hepatitis B vaccine** and, in some cases, **hepatitis B immune globulin (HBIG)**, depending on the exposed person's vaccination status and the source's HBV status.
Question 2: What is the diagnosis of a child with a small abrasion over the face who develops fever with chills, induration, and fiery red swelling over the face extending to the ear?
- A. Anthrax
- B. Carbuncle
- C. Cellulitis
- D. Erysipelas (Correct Answer)
Explanation: ***Erysipelas*** - The presentation of **fiery red swelling** with well-demarcated, raised borders, rapidly extending from a small abrasion, especially on the face and involving the ear, is classic for erysipelas. - It also includes systemic symptoms like **fever and chills** and **induration**, which are characteristic of this superficial skin infection usually caused by **Streptococcus pyogenes**. *Anthrax* - Cutaneous anthrax typically presents with a papule that develops into a **vesicle**, then a painless ulcer with a distinctive **black eschar**, which is not described here. - While it can cause fever, the characteristic skin lesion is distinct from the red, spreading swelling seen in this case. *Carbuncle* - A carbuncle is a deep infection involving multiple hair follicles, presenting as a painful, interconnected lesion with **multiple draining sinuses**. - It is typically more localized, deeper, and pus-filled than the superficial, rapidly spreading, fiery red swelling described. *Cellulitis* - Cellulitis is a deeper infection of the dermis and subcutaneous fat, presenting with redness, warmth, and tenderness, but its borders are typically **less well-demarcated** and not as raised as in erysipelas. - While it can also occur on the face and cause systemic symptoms, the description of "fiery red" and "extending to the ear" with sharp borders makes erysipelas a more precise diagnosis.
Question 3: An organism produces cutaneous disease (malignant pustule or eschar) at the site of inoculation in handlers of animal skins. Most likely organism is:
- A. Neisseria meningitidis
- B. Bacillus anthracis (Correct Answer)
- C. Pseudomonas aeruginosa
- D. Cryptococcus neoformans
Explanation: ***Bacillus anthracis*** - This description is classic for **cutaneous anthrax**, characterized by a **malignant pustule** or **eschar** that develops at the site of inoculation. - The context of handling **animal skins** (e.g., wool-sorter's disease) is a key epidemiological clue for _Bacillus anthracis_ infection. *Neisseria meningitidis* - Primarily causes **meningitis** and **meningococcemia**, involving a petechial or purpuric rash, not a single eschar or malignant pustule. - There is no direct association with handling animal skins. *Pseudomonas aeruginosa* - This bacterium is often associated with **opportunistic infections** in immunocompromised individuals, burn patients, or those with indwelling medical devices. - While it can cause skin lesions (e.g., **ecthyma gangrenosum**), these are distinct from the anthrax eschar and are not linked to animal skin exposure. *Cryptococcus neoformans* - A **fungus** that primarily causes **cryptococcal meningitis** or pulmonary infections, especially in immunocompromised individuals. - Skin manifestations, when they occur, are typically papules, nodules, or ulcers, not the classic **cutaneous anthrax eschar**.
Question 4: Management of non-immunized diphtheria contacts includes all except:
- A. Daily throat examination
- B. Prophylactic penicillin
- C. Daily throat swab culture (Correct Answer)
- D. Weekly throat swab examination
Explanation: ***Daily throat swab culture*** - **Daily throat swab cultures** are not part of standard management for non-immunized diphtheria contacts as they are impractical, resource-intensive, and unnecessary. - Standard practice involves a **single throat/nasal culture** at the time of contact identification to detect carriers, not repeated daily cultures. - Daily clinical surveillance (visual examination) is sufficient for monitoring symptom development. *Daily throat examination* - **Daily clinical throat examination** is a crucial component of contact management for early detection of membrane formation or pharyngitis. - This allows prompt isolation and treatment if symptoms develop during the incubation period (2-5 days). - Visual inspection is practical and cost-effective for daily monitoring. *Prophylactic penicillin* - **Prophylactic antibiotics** (benzathine penicillin single dose IM or 7-10 days of oral erythromycin) are essential for all diphtheria contacts regardless of immunization status. - This eradicates potential colonization with *Corynebacterium diphtheriae* and prevents disease development. - Reduces transmission risk during the incubation period. *Weekly throat swab examination* - While **not part of routine management**, weekly swabs are more reasonable than daily cultures if extended monitoring is needed in special circumstances. - Standard protocol involves a **single culture** at identification, not repeated weekly sampling. - The key distinction: daily cultures are clearly excessive, making this the correct answer for what is NOT included in standard management.
Question 5: Bacillus anthracis is:
- A. Gram negative cocci in cluster
- B. Gram positive rods with square ends (Correct Answer)
- C. Gram positive cocci in cluster
- D. Gram positive bacilli with spherical ends
Explanation: ***Gram positive rods with square ends*** - *Bacillus anthracis* is a **gram-positive bacterium**, meaning it retains the crystal violet stain due to its thick peptidoglycan layer. - Microscopically, it appears as **large, rod-shaped bacteria** (bacilli) with characteristic **square-cut ends**, often arranged in chains. *Gram negative cocci in cluster* - This describes organisms like **Neisseria gonorrhoeae** or **meningitidis**, which are spherical (cocci) and appear pink/red after Gram staining. - *Bacillus anthracis* is a **rod-shaped bacterium** that stains Gram-positive. *Gram positive cocci in cluster* - This morphology is characteristic of **Staphylococcus species**, which are spherical bacteria that stain purple and arrange in grape-like clusters. - *Bacillus anthracis* is a **rod-shaped bacterium**, not a coccus. *Gram positive bacilli with spherical ends* - While *Bacillus anthracis* is a **gram-positive bacillus**, its ends are distinctly **square-cut**, not spherical. - Bacteria with spherical or rounded ends would include some other *Bacillus* species or members of the **Clostridium** genus.
Question 6: A patient with acute leukemia is admitted with febrile neutropenia. On day four of being treated with broad-spectrum antibiotics, his fever increases. Chest X-ray shows bilateral fluffy infiltrates. Which of the following should be the most appropriate next step in the management?
- A. Add antifungal therapy (Correct Answer)
- B. Add antiviral therapy
- C. Add cotrimoxazole
- D. Continue chemotherapy
Explanation: Correct: Add antifungal therapy - Increasing fever despite broad-spectrum antibiotics in a neutropenic patient with bilateral fluffy infiltrates on chest X-ray strongly indicates an underlying fungal infection [1], [3]. - Empirical antifungal therapy is a crucial next step in this high-risk population to prevent severe morbidity and mortality associated with invasive fungal infections [1]. Add antiviral therapy - While viral infections can occur in immunocompromised patients, the presentation of persistent fever despite antibiotics and fluffy infiltrates is less characteristic of a primary viral pneumonia requiring targeted antiviral therapy at this initial stage [2]. - The patient's clinical picture is more suggestive of a fungal etiology after failing antibacterial treatment. Add cotrimoxazole - Cotrimoxazole (trimethoprim/sulfamethoxazole) is primarily used for Pneumocystis jirovecii pneumonia (PCP) prophylaxis or treatment, or for certain bacterial infections. - The clinical scenario, particularly the bilateral fluffy infiltrates in a neutropenic patient failing broad-spectrum antibiotics, is less typical for a PCP presentation and doesn't point to a need for this specific antibiotic. Continue chemotherapy - The patient is currently experiencing febrile neutropenia [2], a life-threatening complication of chemotherapy. - Continuing chemotherapy would further exacerbate the neutropenia and potentially worsen the infection, without addressing the underlying cause of the persistent fever and infiltrates.
Question 7: Pulmonary manifestation for inhalational anthrax is:
- A. Hemorrhagic mediastinitis (Correct Answer)
- B. Lobar consolidation
- C. Bronchopneumonia with type two respiratory failure
- D. Can cause pneumonia
Explanation: ***Hemorrhagic mediastinitis*** - Inhalational anthrax is characterized by the rapid development of **hemorrhagic mediastinitis** due to direct bacterial infection and subsequent toxin-induced vascular damage in the mediastinal lymph nodes. - This leads to a widened mediastinum on chest imaging, often with **pleural effusions** and surrounding edema. *Lobar consolidation* - **Lobar consolidation** is more typical of common bacterial pneumonias, such as those caused by *Streptococcus pneumoniae* or *Klebsiella pneumoniae* [1]. - While pulmonary symptoms occur in anthrax, it is not primarily a direct lobar parenchymal infection but rather an infection of the **mediastinal lymph nodes**. *Bronchopneumonia with type two respiratory failure* - **Bronchopneumonia** involves patchy inflammation centered around bronchioles, which is not the primary pattern of lung involvement in inhalational anthrax. - **Type 2 respiratory failure** (hypercapnic respiratory failure) results from ventilation-perfusion mismatch or hypoventilation, but its direct association with this specific anthrax manifestation is less characteristic compared to the hemorrhagic mediastinitis. *Can cause pneumonia* - While inhalational anthrax can lead to severe pulmonary symptoms and acute respiratory failure, describing it simply as "pneumonia" is insufficient as it fails to capture the unique and critical finding of **hemorrhagic mediastinitis**. - The disease's characteristic features, such as mediastinal widening and hemorrhage, differentiate it from typical bacterial pneumonias.
Question 8: Which of the following is classified as a Category A bioterrorism agent?
- A. Clostridium perfringens
- B. NIPAH virus
- C. Bacillus anthracis (Correct Answer)
- D. Coxiella burnetii
Explanation: ***Bacillus anthracis*** - **Anthrax**, caused by *Bacillus anthracis*, is a prime example of a Category A bioterrorism agent due to its high mortality, ease of dissemination, and potential for major public health impact. - Category A agents pose the **greatest threat** to public health and national security. *Clostridium perfringens* - *Clostridium perfringens* is classified as a **Category B bioterrorism agent**. - While it causes **gas gangrene** and food poisoning with moderate severity, it lacks the **high transmissibility** and widespread impact characteristic of Category A agents. *NIPAH virus* - **Nipah virus** is classified as a Category C priority pathogen. - It has the potential for high morbidity and mortality, but its **epidemiological characteristics** (e.g., lower transmissibility than Category A agents) preclude its inclusion in Category A. *Coxiella burnetii* - *Coxiella burnetii*, the causative agent of **Q fever**, is classified as a Category B bioterrorism agent. - Category B agents are moderately easy to disseminate and can cause **moderate morbidity** and low mortality, which is less severe than Category A agents.
Question 9: Targeted critical agents used in a bioterrorist event are except?
- A. Ricinus communis
- B. Small pox
- C. Coxiella burnetii (Correct Answer)
- D. Viral hemorrhagic fevers -Junin virus
Explanation: ***Coxiella burnetii*** - This is the **correct answer** as it is classified as a **Category B biological agent**, not a Category A critical agent. - While *C. burnetii* causes **Q fever** and has high infectivity with potential for widespread illness, it typically has **lower mortality rates** compared to Category A agents. - Category B agents are second-priority because they are moderately easy to disseminate but cause lower mortality than Category A agents. *Ricinus communis* - This refers to **ricin toxin** derived from castor beans, classified as a **Category B agent**. - However, ricin is considered more dangerous than Q fever due to its potent toxicity and lack of antidote. - Can cause severe multi-organ damage upon inhalation or ingestion, though less lethal than Category A agents. *Smallpox* - Caused by **variola virus**, classified as a **Category A critical agent**. - High infectivity, severe illness, high mortality rate, and lack of natural immunity in most populations. - Historical use as a bioweapon and potential for rapid global spread make it a top-tier threat. *Viral hemorrhagic fevers - Junin virus* - **Category A critical agent** due to high infectivity, severe disease presentation, and high mortality rates. - Includes agents like Ebola, Marburg, Lassa, and Junin viruses that cause severe multi-system disease. - Person-to-person transmission potential and lack of effective treatments make these priority threats.
Question 10: Category A bioterrorism agent is:
- A. Influenza
- B. Anthrax (Correct Answer)
- C. Hendra
- D. Chikungunya
Explanation: **Anthrax** - **Anthrax** is classified as a Category A bioterrorism agent due to its high mortality rate, ease of dissemination, and potential for major public health impact. - Caused by **Bacillus anthracis**, it can be spread through spores, leading to cutaneous, gastrointestinal, or inhalational forms, the latter being the most lethal. *Influenza* - While seasonal **influenza** can cause widespread illness and significant morbidity/mortality, it is typically considered a naturally occurring public health threat rather than a primary bioterrorism agent. - The rapid mutation of influenza viruses makes vaccine development challenging, but it doesn't meet the criteria for a Category A agent's specific risk profile. *Hendra* - **Hendra virus** is a zoonotic virus primarily found in Australia, transmitted from bats to horses and then potentially to humans. - It causes severe, often fatal, respiratory and neurological disease, but its limited geographic range and difficulty in human-to-human transmission exclude it from the highest bioterrorism category. *Chikungunya* - **Chikungunya virus** is a mosquito-borne illness causing fever and severe joint pain, primarily in tropical and subtropical regions. - While it can cause significant public health issues due to outbreaks, it typically has a low mortality rate and is not easily aerosolized or engineered for mass casualties, thus not classified as a Category A agent.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free